Home » Topics » Regulatory

Regulatory
RSS

Once-weekly Fosamax approved by FDA

Oct. 24, 2000

Prilosec receives positive recommendation for OTC status

Oct. 24, 2000

SkyePharma's Solaraze earns FDA approval

Oct. 23, 2000

Meningococcal C meningitis vaccine approved for very young infants

Oct. 19, 2000

Dimethaid Research seeks approval for topical osteoarthritis treatment in Canada

Oct. 18, 2000

Glucophage XR: once-daily type 2 diabetes drug approved by FDA

Oct. 18, 2000

Aradigm completes phase II trial with AERx delivery of dornase alfa for CF patients

Oct. 18, 2000

Extended-release Lescol XL cleared by FDA for cholesterol reduction

Oct. 17, 2000

FDA approves Novantrone for worsening forms of multiple sclerosis

Oct. 17, 2000

SangStat obtains technology to develop smaller ciclosporin capsule

Oct. 16, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.